Mikael has over 25 years of experience in the medical device industry, including 9 years at Abbott Vascular / Guidant and 7 years at CapsoVision. He is a coinventor of over 100 granted US patents for various drug delivery and medical device therapies. Prior to Resurge, Mikael worked on drug delivery for solid tumors as Senior VP at TriSalus Lifesciences which is now a publicly traded company. He received his PhD from the Royal Institute of Technology, Sweden, and was a Fulbright Fellow at Stanford University

John is a proven technical leader with over 20 years of experience in local drug delivery including 8 years at Abbott Vascular / Guidant. He is passionate about innovation and has been granted over 65 US patents. Prior to Resurge, John was VP of R&D and Clinical at Intersect ENT, which went IPO and eventually was acquired by Medtronic for more than $1B. John received his PhD in chemical engineering from University of Pittsburgh.

Shahram is an internationally recognized urologist in Silicon Valley affiliated with Good Samaritan Hospital and Stanford University. He has been a part of 15 clinical studies as principal investigator and is a respected industry advisor with prior experience as CMO at KDX Diagnostic and partner at Boss Surgical. Shahram received his MD from Boston University, completed fellowships in surgery and urology at UCSF and fellowships in urologic laparoscopic oncology at the University of Paris.

James brings over 25 years of legal and patent law experience to Resurge. He has represented a wide range of pharmaceutical and medical device companies and created significant intellectual property related to drug delivery, bioabsorbable, and smart pill technologies. He has worked at internationally renowned law firms including Squire Patton Boggs LLP, Buchanan Ingersoll & Rooney PC, and Morgan Lewis as well as in-house at General Electric Aviation.